SCHEMBL19650653

SCHEMBL19650653

c1ccc(-c2cc(-c3ccc(-c4ccc(-c5cccnc5)cc4)cc3)nc(-c3cccc(-c4cccc5ccccc45)c3)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.51
ALDH1A1 P00352 4/20 0.51
MAPT P10636 3/20 0.51
HPGD P15428 3/20 0.51
RAB9A P51151 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
DHODH Q02127 1/20 0.51
CYP19A1 P11511 2/20 0.49
TNF P01375 1/20 0.48
CYP11B1 P15538 2/20 0.47
CYP17A1 P05093 1/20 0.46
CYP11B2 P19099 1/20 0.46
CYP2C9 P11712 4/20 0.43
GLA P06280 2/20 0.41
GAA P10253 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17918046 1.00 KDM4E (0.51) KDM4EALDH1A1MAPTHPGDRAB9A
SCHEMBL30297006 1.00 KDM4E (0.51) KDM4EALDH1A1MAPTHPGDRAB9A
SCHEMBL17807973 0.97 DHODH (0.49) KDM4EALDH1A1MAPTHPGDRAB9A
SCHEMBL17808142 0.97 DHODH (0.49) KDM4EALDH1A1MAPTHPGDRAB9A
SCHEMBL17808049 0.97 KDM4E (0.51) KDM4EALDH1A1MAPTHPGDRAB9A
SCHEMBL17917892 0.97 ALDH1A1 (0.51) KDM4EALDH1A1MAPTHPGDRAB9A
SCHEMBL23095091 0.96 KDM4E (0.50) KDM4EALDH1A1MAPTHPGDRAB9A
SCHEMBL19397481 0.96 ALDH1A1 (0.50) KDM4EALDH1A1MAPTHPGDRAB9A
SCHEMBL19397428 0.95 ALDH1A1 (0.54) KDM4EALDH1A1MAPTHPGDRAB9A
SCHEMBL19397594 0.94 ALDH1A1 (0.50) KDM4EALDH1A1MAPTHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3248966-B1 PYRIMIDINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES HODOGAYA CHEMICAL CO LTD (JP) 2022-12-21 EP disclosed
US-10950797-B2 Organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2021-03-16 US disclosed
US-10566543-B2 Pyrimidine derivative and organic electroluminescent devices HODOGAYA CHEMICAL CO., LTD. (JP) 2020-02-18 US disclosed
EP-3248966-A1 PYRIMIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT Hodogaya Chemical Co., Ltd. (JP) 2017-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10566543-B2 Pyrimidine derivative and organic electroluminescent devices TYMS, TYMP, DPYD KDM4E 2447/4885ALDH1A1 582/4885MAPT 2249/4885
US-10950797-B2 Organic electroluminescent device SLC29A2, SLC29A1, NUDT1 KDM4E 1386/4885ALDH1A1 427/4885MAPT 2001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.